All Stories

  1. Glomerular transcriptomics predicts long term outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy
  2. Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
  3. Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla−/− zebrafish model of Fabry disease
  4. Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts
  5. Deoxyribonucleoside treatment rescues EtBr‐induced mtDNA depletion in iPSC‐derived neural stem cells with POLG mutations
  6. Network-Based Assessment of Minimal Change Disease Identifies Glomerular Response to IL-7 and IL-12 Pathways Activation as Innovative Treatment Target
  7. Gene Expression Analysis in gla-Mutant Zebrafish Reveals Enhanced Ca2+ Signaling Similar to Fabry Disease
  8. A multiomics disease progression signature of low-risk ccRCC
  9. Association of redox and inflammation-related biomarkers with prognosis in IgA nephropathy: A prospective observational study
  10. Reduced α-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype
  11. Characterisation of disease progression in low-risk renal cell carcinoma patients by multiomics data
  12. Variable expression of eighteen common housekeeping genes in human non-cancerous kidney biopsies
  13. AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease
  14. AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model
  15. Analysis of Salivary Mycobiome in a Cohort of Oral Squamous Cell Carcinoma Patients From Sudan Identifies Higher Salivary Carriage of Malassezia as an Independent and Favorable Predictor of Overall Survival
  16. Axl‐inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model
  17. Successful therapy of experimental, orthotopic renal cell carcinoma with two different types of Axl inhibiting agents
  18. PARTIAL EPITHELIAL-TO-MESENCHYMAL TRANSITION AND T CELL-MEDIATED INFLAMMATION IN BENIGN NEPHROSCLEROSIS AND DIABETIC NEPHROPATHY
  19. Preliminary proteomic analysis reveals less abundant endosome-related proteins in - knockout zebrafish ()
  20. Stem cell derived astrocytes with POLG mutations and mitochondrial dysfunction including abnormal NAD+ metabolism is toxic for neurons
  21. Disease‐specific phenotypes in iPSC ‐derived neural stem cells with POLG mutations
  22. Circulating inflammation-related factors are correlated with systemic redox status in IgA nephropathy; a case-control study
  23. FP336AXL INHIBITION PREVENTED MITOCHONDRIAL DYSFUNCTION IN UNILATERAL URETERAL OBSTRUCTION
  24. AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction
  25. Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma
  26. Abstract 135: Associations between VEGF polymorphisms and clinical outcome in breast cancer
  27. Oxidative stress in susceptibility to breast cancer: study in Spanish population
  28. Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer
  29. Epistatic interaction of Arg72Pro TP53 and −710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival
  30. Identification of Candidate Polymorphisms on Stress Oxidative and DNA Damage Repair Genes Related with Clinical Outcome in Breast Cancer Patients
  31. The single-nucleotide polymorphisms +936 C/T VEGF and −710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population
  32. P3-14-05: Evaluation of Residual Cancer Burden Index (RCBI) as a Predictor of Disease Free Survival in a Non-Selected Cohort of Breast Cancer Patients Treated in the Neoadjuvant Setting.
  33. 111 VEGF, VEGFR1 and bFGF gene polymorphisms and chronic lymphocytic leukemia
  34. 760 Relationship between NF-kappaB and different clinical-pathological standard factors
  35. Relation of activation of NFkB family members and clinical-pathological factors in breast cancer
  36. Oestradiol or genistein rescues neurons from amyloid beta-induced cell death by inhibiting activation of p38